Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Study of Attitudes About the Risk of Developing Type 2 Diabetes
This study has been completed.
Sponsors and Collaborators: Eastern Virginia Medical School
Centers for Disease Control and Prevention
Association of Teachers of Preventive Medicine
Information provided by: Eastern Virginia Medical School
ClinicalTrials.gov Identifier: NCT00323349
  Purpose

Diabetes mellitus (DM) type 2 is well recognized as a major cause of morbidity and mortality in the United States, as well as a significant contributor to health disparities within the population. Changes in demographic and lifestyle characteristics in the population have led to a progressive increase in the prevalence of both diabetes and impaired glucose tolerance (IGT), a precursor to DM type 2. Although pharmacologic interventions have proven to be successful in blocking the progression from IGT to DM, they have not been as effective as diet and exercise modification. Studies of behavioral interventions in IGT have focused on the outcomes of improved DM risk factors and decreased progression to DM, but have either required extensive interventions that lack applicability to the general population or have utilized more modest interventions with no effect on risk factors. These studies have not included impact evaluations to assess the effect of knowledge of IGT status on motivation to change and perceived risk. This study will assess the impact of knowledge of IGT on the likelihood of altering health-related behaviors, utilizing the Health Belief Model as a conceptual framework. Subjects will be randomized to one of four treatment arms, organized in a factorial design to (1) assess the impact of OGTT testing on motivation to change behaviors and (2) evaluate the efficacy of a novel educational intervention linked to patients' learning styles. This evaluation will determine whether OGTT testing is more beneficial as a cue to action to motivate behavior change than a multifactorial assessment of diabetes risk. Additionally, the improvement in health motivation after an educational intervention is expected to be enhanced when the educational method is tailored to the individual's preferred learning style. This information will provide the foundation for more efficient behavioral interventions for patients at high risk for DM type 2.


Condition Intervention
Prediabetic State
Procedure: Oral Glucose Tolerance Testing
Behavioral: Education tailored to learning style preferences

MedlinePlus related topics: Diabetes
Drug Information available for: Dextrose
U.S. FDA Resources
Study Type: Interventional
Study Design: Randomized, Open Label, Active Control, Factorial Assignment, Efficacy Study
Official Title: Cues to Action in Diabetes Risk Education (CADRE): Randomized Study Assessing the Impact of Knowledge of Impaired Glucose Tolerance on Perceived Risk and Behavior Change Motivation

Further study details as provided by Eastern Virginia Medical School:

Primary Outcome Measures:
  • Scores on perceived risk scale after the intervention
  • Scores on motivation to change behavior scale after the intervention

Secondary Outcome Measures:
  • Scores on scales of perceived benefits of healthy lifestyle choices
  • Scores on scales of perceived barriers to healthy lifestyle choices

Estimated Enrollment: 276
Study Start Date: April 2003
Estimated Study Completion Date: December 2004
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Increased risk for diabetes type 2 by one of the following characteristics: (1) BMI>30, (2) Age>45, (3) First-degree relative with type 2 diabetes, (4) History of gestational diabetes, (5) Prior elevated fasting glucose in the previous year.

Exclusion Criteria:

  • History of diabetes (not gestational diabetes)
  • Current laboratory results consistent with diabetes
  • Current pregnancy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00323349

Locations
United States, Virginia
Ghent Family Practice
Norfolk, Virginia, United States, 23507
Portsmouth Family Medicine
Portsmouth, Virginia, United States, 23707
Sponsors and Collaborators
Eastern Virginia Medical School
Association of Teachers of Preventive Medicine
Investigators
Principal Investigator: Laura E Eizember, MD Eastern Virginia Medical School
  More Information

Study ID Numbers: TS-0931
Study First Received: May 6, 2006
Last Updated: June 27, 2007
ClinicalTrials.gov Identifier: NCT00323349  
Health Authority: United States: Institutional Review Board

Keywords provided by Eastern Virginia Medical School:
Glucose Tolerance Test
Health Knowledge, Attitudes, Practice
Motivation
Communication
Health Behavior

Study placed in the following topic categories:
Metabolic Diseases
Glucose Intolerance
Diabetes Mellitus, Type 2
Prediabetic State
Diabetes Mellitus
Endocrine System Diseases
Endocrinopathy
Metabolic disorder
Glucose Metabolism Disorders

ClinicalTrials.gov processed this record on January 14, 2009